| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. | Director | Stock Option (right to buy) | 14,750 | 26 Jun 2025 | Direct | ||
| Artiva Biotherapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 13,750 | 24 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | 26 Jun 2025 | 1 | $0 | 4 | Director | 26 Jun 2025, 17:39 |
| ARTV | Artiva Biotherapeutics, Inc. | 24 Jun 2025 | 1 | $0 | 4 | Director | 26 Jun 2025, 16:30 |
| CTNM | Contineum Therapeutics, Inc. | 14 Mar 2025 | 1 | $0 | 4 | Director | 17 Mar 2025, 16:12 |
| CTNM | Contineum Therapeutics, Inc. | 14 Mar 2025 | 0 | $0 | 3 | Director | 17 Mar 2025, 16:10 |
| ARTV | Artiva Biotherapeutics, Inc. | 18 Jul 2024 | 0 | $0 | 3 | Director | 18 Jul 2024, 20:06 |